Antiviral Agents/pharmacology; Betacoronavirus; Coronavirus Infections; Heart; Myocarditis; Myocytes, Cardiac; Pandemics; Pneumonia, Viral; Angiotensin-Converting Enzyme 2; Betacoronavirus/drug effects; Betacoronavirus/pathogenicity; Betacoronavirus/physiology; COVID-19; Coronavirus Infections/drug therapy; Coronavirus Infections/metabolism; Coronavirus Infections/physiopathology; Coronavirus Infections/prevention & control; Drug Development/methods; Drug Development/trends; Enzyme Inhibitors/pharmacology; Heart/drug effects; Heart/physiopathology; Heart/virology; Humans; Myocarditis/metabolism; Myocarditis/physiopathology; Myocarditis/prevention & control; Myocarditis/virology; Myocytes, Cardiac/physiology; Myocytes, Cardiac/virology; Pandemics/prevention & control; Peptidyl-Dipeptidase A/metabolism; Pneumonia, Viral/drug therapy; Pneumonia, Viral/metabolism; Pneumonia, Viral/physiopathology; Pneumonia, Viral/prevention & control; SARS-CoV-2; Virus Internalization/drug effects